MillerKnoll Inc
XBER:MHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MillerKnoll Inc
XBER:MHR
|
US |
|
I
|
Iovance Biotherapeutics Inc
LSE:0JDK
|
US |
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
|
H
|
Heng Leasing and Capital PCL
SET:HENG
|
TH |
|
Jardine Matheson Holdings Ltd
OTC:JARLF
|
HK |
|
I
|
International Flavors & Fragrances Inc
DUS:IFF
|
US |
|
P
|
Prudential PLC
XBER:PRU
|
UK |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
C
|
Chargeurs SA
F:GET
|
FR |
|
V
|
Verizon Communications Inc
DUS:BAC
|
US |
|
D
|
Dover Corp
XMUN:DOV
|
US |
|
A
|
Atlas Arteria Group
F:M82
|
AU |
|
XPS Pensions Group PLC
LSE:XPS
|
UK |
|
B
|
Baozun Inc
XBER:2BZA
|
CN |
|
T
|
Takeda Pharmaceutical Co Ltd
F:TKDA
|
JP |
|
M P Evans Group PLC
F:NYP
|
UK |
|
F
|
Funko Inc
F:FU2
|
US |
|
Vaxart Inc
OTC:VXRT
|
US |
|
H
|
Huazhu Group Ltd
NASDAQ:HTHT
|
CN |
|
Cantaloupe Inc
F:UTE0
|
US |
|
Atlanta Braves Holdings Inc
F:E45
|
US |
|
Mauna Kea Technologies SA
F:1MK
|
FR |
|
Finwise Bancorp
NASDAQ:FINW
|
US |
|
Cherry SE
F:C3RY
|
DE |
Wall St Price Targets
MHR Price Targets Summary
MillerKnoll Inc
According to Wall Street analysts, the average 1-year price target for MHR is 32.32 EUR with a low forecast of 32.01 EUR and a high forecast of 33.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MHR's stock price target?
Price Target
32.32
EUR
According to Wall Street analysts, the average 1-year price target for MHR is 32.32 EUR with a low forecast of 32.01 EUR and a high forecast of 33.27 EUR.
What is the Revenue forecast for MillerKnoll Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for MillerKnoll Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 13%.